Opendata, web and dolomites
H2020 projects about "multicentre"
The page lists 26 projects related to the topic "multicentre".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | OPERAM | OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly | 2015 |
| 3 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 4 | SCIENCE | Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) | 2015 |
| 5 | Paediatric LMS | Non-Invasive Quantitative Magnetic Resonance for Obese Children – the Paediatric LiverMultiScan Test | 2015 |
| 6 | QuantOnCal | Feasibility study for clinical validation of an innovative point of care assay for the detection of low-grade-infections in joint replacement | 2015 |
| 7 | RESSTORE | REgenerative Stem cell therapy for STroke in Europe | 2015 |
| 8 | BOOSTB4 | Boost Brittle Bones Before Birth | 2016 |
| 9 | MemoMCI | Targeting reconsolidation to strengthen memories in individuals with Mild Cognitive Impairment | 2016 |
| 10 | Digi-NewB | Non-invasive monitoring of perinatal health through multiparametric digital representation of clinically relevant functions for improving clinical intervention in neonatal units (Digi-NewB) | 2016 |
| 11 | PreclinSR | Increasing clinical translation of experimental stroke research: new approaches to systematic review | 2016 |
| 12 | ReGenHeart | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study | 2017 |
| 13 | RESPINE | REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy | 2017 |
| 14 | PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | 2017 |
| 15 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
| 16 | IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | 2017 |
| 17 | TruVue | A novel and easy to interpret patient safety monitor, for the diagnosis and management of cardiac function, fluid delivery and drug administration during surgery and intensive care. | 2017 |
| 18 | MCDS-Therapy | Repurposing of carbamazepine for treatment of skeletal dysplasia | 2017 |
| 19 | RE-DEFINE | Refugee Emergency: DEFining and Implementing Novel Evidence-based psychosocial interventions | 2018 |
| 20 | HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial | 2018 |
| 21 | LEGACy | CeLac and European consortium for a personalized medicine approach to Gastric Cancer | 2019 |
| 22 | BiocatSusChem | Biocatalysis for Sustainable Chemistry – Understanding Oxidation/Reduction of Small Molecules by Redox Metalloenzymes via a Suite of Steady State and Transient Infrared Electrochemical Methods | 2019 |
| 23 | RECODID | Integrated human data repositories for infectious disease-related international cohorts to foster personalized medicine approaches to infectious disease research | 2019 |
| 24 | PD-MIND | Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug | 2019 |
| 25 | BornToGetThere | Implementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal health | 2020 |
| 26 | DECODE | reDucing the health and Economic COst of Diagnostic uncErtainty: launch and randomized control trial of the first validated bacterial versus viral test | 2020 |